title: Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer.
authors.affiliation: Department of Biochemistry & Molecular Medicine, University of California Davis, Sacramento, CA 95817, USA.
authors.forename: Ruiwu
authors.initials: R
authors.lastname: Liu
authors.forename: Hiromi I
authors.initials: HI
authors.lastname: Wettersten
authors.forename: See-Hyoung
authors.initials: SH
authors.lastname: Park
authors.forename: Robert H
authors.initials: RH
authors.lastname: Weiss
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D059447:Cell Cycle Checkpoints / Q000187:drug effects; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D050759:Cyclin-Dependent Kinase Inhibitor p21; D034741:RNA, Small Interfering; D054852:Small Molecule Libraries